An Phat Bioplastics JSC

An Phat Bioplastics JSC operates with a negative free cash flow of -728.3 billion VND, indicating a cash outflow from operations after capital expenditures, which may signal liquidity constraints or high reinvestment needs. The company's return on assets of 2.89% is below the typical benchmark for capital efficiency in the packaging industry, suggesting that the company is not generating strong returns relative to its asset base. The company's profitability is reflected in a gross profit of 1.49 trillion VND and an operating income of 562.1 billion VND, but the net income of 372.9 billion VND is relatively modest compared to its revenue of 10.73 trillion VND, indicating a net margin of approximately 3.47%. This margin is not provided for comparison against industry medians, but the low return on assets suggests that the company's profitability is not translating into strong asset returns. The company's revenue is primarily concentrated in the sale of finished plastic products, with 92.5% of revenue derived from this segment as of 2012. There is no recent data on geographic or segment diversification, but the historical concentration in a single product line may expose the company to demand volatility in the plastic packaging market. There is no available growth trajectory data for the company in the current period, and no numeric deltas are provided for the current or next fiscal year. The company's historical revenue growth is not specified, but the negative free cash flow and low return on assets may indicate challenges in sustaining growth without external financing. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The dilution risk is currently rated as low, but the absence of detailed capital structure data makes it difficult to assess the potential for future dilution. No adjustments have been applied to the valuation metrics, and there is no indication of recent capital-raising activities. There are no recent events, filings, or transcripts provided in the input data to inform the company's current strategic or operational developments. The absence of recent disclosures limits the ability to assess the company's response to market conditions or regulatory changes.